Strategy Combines and Repurposes Drugs for Eye Disease (1 of 2) (IMAGE)

American Association for the Advancement of Science (AAAS)

Strategy Combines and Repurposes Drugs for Eye Disease (1 of 2)

Caption

Toluidine blue-stained retinal sections from Abca4?/?Rdh8?/? mice unexposed to bright light or at 3 hours after light exposure. White lines outline the outer plexiform layer.. This material relates to a paper that appeared in the July 26, 2016, issue of Science Signaling, published by AAAS. The paper, by Y. Chen at Shanghai University of Traditional Chinese Medicine in Shanghai, China, and colleagues was titled, Synergistically acting agonists and antagonists of G protein-coupled receptors prevent photoreceptor cell degeneration.'

Credit

Y. Chen <i>et al., Science Signaling</i> (2016)

Usage Restrictions

Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact <i>Science</i> for permission.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.